Search Results - "Florin, Floricel"

Refine Results
  1. 1

    Treatment with brivaracetam has no apparent long-term effects on body weight in pediatric patients with epilepsy by Floricel, Florin I, Reichel, Paula E, Dickson, Najla, Fleyshman, Sofia, Reichel, Christoph, Elshoff, Jan-Peer

    Published in Epilepsia open (02-10-2024)
    “…The objective of this study is to evaluate possible long-term effects of treatment with brivaracetam (BRV) on body weight in children with epilepsy. Post hoc…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures: A multicenter, open‐label, single‐arm study by Pressler, Ronit, Boylan, Geraldine, Dempsey, Eugene, Klotz, Kerstin Alexandra, Krauwinkel, Walter, Will, Edgar, Morita, Diego, Floricel, Florin, Elshoff , Jan‐Peer, Anker, John

    Published in Epilepsia open (01-04-2024)
    “…Objective To evaluate the pharmacokinetics (PK), safety, and tolerability of brivaracetam (BRV) in neonates with repeated electroencephalographic seizures not…”
    Get full text
    Journal Article
  3. 3

    Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design by Bast, Thomas, Schulz, Anne‐Liv, Floricel, Florin, Morita, Diego, Cleveland, Jody M., Elshoff, Jan‐Peer

    Published in Epilepsia open (01-12-2022)
    “…Objective Despite introduction of several antiseizure medications over the past two decades, treatment options for childhood absence epilepsy (CAE) and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Congenital ocular motor apraxia: Clinical and neuroradiological findings, and long-term intellectual prognosis by Kondo, Akiko, Saito, Yoshiaki, Floricel, Florin, Maegaki, Yoshihiro, Ohno, Kousaku

    Published in Brain & development (Tokyo. 1979) (01-08-2007)
    “…The severity of intellectual sequelae and prognosis varies in patients with congenital ocular motor apraxia (COMA). Here, we explored this phenomenon with…”
    Get full text
    Journal Article
  6. 6

    Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells by Floricel, Florin, Higaki, Katsumi, Maki, Hirotoshi, Nanba, Eiji, Ninomiya, Haruaki, Ohno, Kousaku

    Published in Brain & development (Tokyo. 1979) (01-09-2007)
    “…Tuberous sclerosis complex (TSC) is an autosomal dominant inherited disorder characterized by benign tumors (hamartomas) in various organs. The brain is one of…”
    Get full text
    Journal Article
  7. 7

    Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open‐label exploratory trial by Auvin, Stéphane, Arzimanoglou, Alexis, Beller, Cynthia, Floricel, Florin, Daniels, Tony, Bozorg, Ali

    Published in Epilepsia (Copenhagen) (01-11-2023)
    “…Objective To evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of lacosamide (LCM) (up to 12 mg/kg/day or 600 mg/day) as adjunctive…”
    Get full text
    Journal Article
  8. 8

    Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials by Ryvlin, Philippe, Dimova, Svetlana, Elmoufti, Sami, Floricel, Florin, Laloyaux, Cédric, Nondonfaz, Xavier, Biton, Victor

    Published in Epilepsia (Copenhagen) (01-08-2022)
    “…Objective This study was undertaken to evaluate safety/tolerability and efficacy of adjunctive brivaracetam (BRV) in patients on one or two concomitant…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures by Meador, Kimford J., Dimova, Svetlana, Bourikas, Dimitrios, Elmoufti, Sami, Floricel, Florin, Laloyaux, Cédric, Moseley, Brian, Nondonfaz, Xavier, Klein, Pavel

    Published in Epilepsy & behavior (01-07-2024)
    “…[Display omitted] •11% on BRV vs. 4.8% on PBO had drug-related psychiatric/behavioral (P/B) TEAEs.•Most patients had mild/moderate P/B TEAEs and did not…”
    Get full text
    Journal Article
  16. 16

    Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial by Lagae, Lieven, Klotz, Kerstin Alexandra, Fogarasi, András, Floricel, Florin, Reichel, Christoph, Elshoff, Jan‐Peer, Fleyshman, Sofia, Kang, Harriet

    Published in Epilepsia (Copenhagen) (01-11-2023)
    “…Objective This study was undertaken to evaluate the long‐term safety, tolerability, and efficacy of adjunctive brivaracetam (BRV) treatment in pediatric…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20